Andy Chen

Assistant Professor

  • 1136 Citations
  • 16 h-Index
19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Andy Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Cell Transplantation Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
OX40 Ligand Medicine & Life Sciences
Transplants Medicine & Life Sciences
Autologous Transplantation Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 1136 Citations
  • 16 h-Index
  • 31 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Review article

Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310)

Byrd, J. C., Smith, S., Wagner-Johnston, N., Sharman, J., Chen, A., Advani, R., Augustson, B., Marlton, P., Renee Commerford, S., Okrah, K., Liu, L., Murray, E., Penuel, E., Ward, A. F. & Flinn, I. W., Jan 1 2019, In : Oncotarget. 10, 38, p. 3827-3830 4 p.

Research output: Contribution to journalComment/debate

Open Access
B-Lymphocytes
2 Citations (Scopus)

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

Tilly, H., Morschhauser, F., Bartlett, N. L., Mehta, A., Salles, G., Haioun, C., Munoz, J., Chen, A., Kolibaba, K., Lu, D., Yan, M., Penuel, E., Hirata, J., Lee, C. & Sharman, J. P., Jul 1 2019, In : The Lancet Oncology. 20, 7, p. 998-1010 13 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Prednisone
Doxorubicin
Cyclophosphamide
Safety
3 Citations (Scopus)

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

Morschhauser, F., Flinn, I. W., Advani, R., Sehn, L. H., Diefenbach, C., Kolibaba, K., Press, O. W., Salles, G., Tilly, H., Chen, A., Assouline, S., Cheson, B. D., Dreyling, M., Hagenbeek, A., Zinzani, P. L., Jones, S., Cheng, J., Lu, D., Penuel, E., Hirata, J. & 3 others, Wenger, M., Chu, Y. W. & Sharman, J., May 1 2019, In : The Lancet Haematology. 6, 5, p. e254-e265

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Neutropenia
pinatuzumab vedotin

Acute promyelocytic leukemia presenting with features of metastatic osseous disease

Winters, C., Chen, A., Moore, S., Traer, E. & Dunlap, J., Jan 1 2018, In : Leukemia Research Reports. 9, p. 36-37 2 p.

Research output: Contribution to journalArticle

Acute Promyelocytic Leukemia
Chromosomes, Human, Pair 15
Chromosomes, Human, Pair 17
Pancytopenia
Acute Myeloid Leukemia
19 Citations (Scopus)

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis

Casulo, C., Friedberg, J. W., Ahn, K. W., Flowers, C., DiGilio, A., Smith, S. M., Ahmed, S., Inwards, D., Aljurf, M., Chen, A., Choe, H., Cohen, J., Copelan, E., Farooq, U., Fenske, T. S., Freytes, C., Gaballa, S., Ganguly, S., Jethava, Y., Kamble, R. T. & 16 others, Kenkre, V. P., Lazarus, H., Lazaryan, A., Olsson, R. F., Rezvani, A. R., Rizzieri, D., Seo, S., Shah, G. L., Shah, N., Solh, M., Sureda, A., William, B., Cumpston, A., Zelenetz, A. D., Link, B. K. & Hamadani, M., Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Follicular Lymphoma
Autologous Transplantation
Secondary Prevention
Bone Marrow
Transplants